Prophylactic Tranexamic Acid During Minimally Invasive Myomectomies

Inclusion Criteria: * Undergoing laparoscopic myomectomy * At least one fibroid greater than or equal to 6 cm * Any intramural or broad ligament fibroid greater than or equal to 4 cm * At least 3 total fibroids based on preoperative imaging Exclusion Criteria: * Severe existing medical complications involving the heart, liver, or kidney * Moderate to severe renal impairment (serum creatinine \> 1.4) * Blood clotting abnormalities * Known Allergies to tranexamic acid * Known Contraindications to Minimally invasive myomectomies * If you are pregnant * History of a prior blood clot in the lung arm or leg, known as pulmonary embolism or deep vein thrombosis * Any active blood clots, clotting disease, pulmonary embolism, cerebral thrombosis, estrogen use, renal impairment, elevated creatinine level * History of a stroke or mini-strokes * Concurrent oral contraceptive use * Contraindications to receiving Tranexamic acid * In patients with acquired defective color vision, since this prohibits measuring one endpoint that should be followed as a measure of toxicity * In patients with subarachnoid hemorrhage. Anecdotal experience indicates that cerebral edema and cerebral infarction may be caused by tranexamic acid in such patients. * In patients with active intravascular clotting. * In patients with hypersensitivity to tranexamic acid or any of the ingredients